CoChat

Prefrontal networks dynamically related to recovery from major depressive disorder: a longitudinal pharmacological fMRI study

Open access

The DOI matches its Crossref record; 88 of the 89 references it cites were found in a registry or an index.

Abstract

Due to lacking predictors of depression recovery, successful treatment of major depressive disorder (MDD) is frequently only achieved after therapeutic optimization leading to a prolonged suffering of patients. This study aimed to determine neural prognostic predictors identifying non-remitters prior or early after treatment initiation. Moreover, it intended to detect time-sensitive neural mediators indicating depression recovery. This longitudinal, interventional, single-arm, open-label, phase IV, pharmacological functional magnetic resonance imaging (fMRI) study comprised four scans at important stages prior (day 0) and after escitalopram treatment initiation (day 1, 28, and 56). Totally, 22 treatment-free MDD patients (age mean ± SD: 31.5 ± 7.7; females: 50%) suffering from a concurrent major depressive episode without any comorbid DSM-IV axis I diagnosis completed the study protocol. Primary outcome were neural prognostic predictors of depression recovery. Enhanced de-activation of anterior medial prefrontal cortex (amPFC, single neural mediator) indicated depression recovery correlating with MADRS score and working memory improvements. Strong dorsolateral PFC (dlPFC) activation and weak dlPFC-amPFC, dlPFC-posterior cingulate cortex (PCC), dlPFC-parietal lobe (PL) coupling (three prognostic predictors) hinted at depression recovery at day 0 and 1. Preresponse prediction of continuous (dlPFC-PL: R 2day1 = 55.9%, 95% CI: 22.6–79%, P < 0.005) and dichotomous (specificity/sensitivity: SP/SN day1 = 0.91/0.82) recovery definitions remained significant after leave-one-out cross-validation. Identified prefrontal neural predictors might propel the future development of fMRI markers for clinical decision making, which could lead to increased response rates and adherence during acute phase treatment periods. Moreover, this study underscores the importance of the amPFC in depression recovery.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41398-019-0395-8

Cites

88 of 88 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Neural mediator and prognostic predictors of depression recovery. a Clusters of significant prognostic value (FWE corrected) for DR (n = 22). b Neural mediator: Enhanced amPFC (orange) de-activation indicates improvements of depressive symptoms. Prognostic predictors: All four scans showed comparable results even weeks ahead of initial clinical response. Stronger dlPFC activation (green) accompanied by weaker dlPFC-amPFC (blue), dlPFC-PCC (cyan), and dlPFC-PL (purple) functional connectivity predicts beneficial depression recovery. Connectivity results for PL are related to 0-back conditions and therefore context-dependent. Healthy subjects: Density plots (right column) demonstrate no significant difference of imaging measures between MDD patients and matched healthy controls (HC) when comparing baseline data on a cross-sectional basis. amPFC anterior medial prefrontal cortex, dlPFC dorsolateral PFC, PCC posterior cingulate cortex, PL parietal lobe, 2B-0B 2-back vs. 0-back contrast
Fig. 1 Neural mediator and prognostic predictors of depression recovery. a Clusters of significant prognostic value (FWE corrected) for DR (n = 22). b Neural mediator: Enhanced amPFC (orange) de-activation indicates improvements of depressive symptoms. Prognostic predictors: All four scans showed comparable results even weeks ahead of initial clinical response. Stronger dlPFC activation (green) accompanied by weaker dlPFC-amPFC (blue), dlPFC-PCC (cyan), and dlPFC-PL (purple) functional connectivity predicts beneficial depression recovery. Connectivity results for PL are related to 0-back conditions and therefore context-dependent. Healthy subjects: Density plots (right column) demonstrate no significant difference of imaging measures between MDD patients and matched healthy controls (HC) when comparing baseline data on a cross-sectional basis. amPFC anterior medial prefrontal cortex, dlPFC dorsolateral PFC, PCC posterior cingulate cortex, PL parietal lobe, 2B-0B 2-back vs. 0-back contrastCC BY · PubMed Central
Fig. 2 Working memory performance and mediator of depression recovery. a Depression symptoms (first y-axis) and n-back working memory performance (2B accuracy, %, second y-axis) improvements were strongest from day 1 to day 28, and tend to normalize compared to healthy subjects (right density plot). This might suggest working memory performance as cognitive correlate of depression symptoms. b A correlation of working memory performance and amPFC de-activation after first improvements (from day 28 to day 56) indicates that enhanced DMN suppression is beneficial for both, depression symptoms and working memory performance. + trendwise significant (P < 0.10), *,** significant (P < 0.05, 0.01), amPFC anterior medial prefrontal cortex, DMN default mode network, MADRS Montgomery-Åsberg Depression Rating Scale, R2 explained variance
Fig. 2 Working memory performance and mediator of depression recovery. a Depression symptoms (first y-axis) and n-back working memory performance (2B accuracy, %, second y-axis) improvements were strongest from day 1 to day 28, and tend to normalize compared to healthy subjects (right density plot). This might suggest working memory performance as cognitive correlate of depression symptoms. b A correlation of working memory performance and amPFC de-activation after first improvements (from day 28 to day 56) indicates that enhanced DMN suppression is beneficial for both, depression symptoms and working memory performance. + trendwise significant (P < 0.10), *,** significant (P < 0.05, 0.01), amPFC anterior medial prefrontal cortex, DMN default mode network, MADRS Montgomery-Åsberg Depression Rating Scale, R2 explained varianceCC BY · PubMed Central
Fig. 3 Diagnostic ability of imaging predictors to anticipate depression recovery: leave-one-out cross-validation (solid line, CV, n − 1 patients) vs. full sample effect size estimations (dashed line, n patients). a Explained variance remained large for all univariate models (single brain regions) prior clinical response (day 0 and especially day 1). ROC curves display the ability of the dlPFC-PL functional connectivity to differentiate also between dichotomous outcomes (remitters and non-remitters) prior a clinically observable response (day 0 and 1). Sensitivity (true positive rate) informs about correct remitter detection and specificity (1—false positive rate) about nonremitter detection. b Effect size remained similar for the multivariate model (all brain regions) after cross-validation. Overfitting, indicated by a large difference between dashed and solid lines, occurred predominantly using multivariate models at late trial stages (day 28 and day 56). This indicates shared information within this system of brain regions (for more details see Figures S4, S5 and Tables S3, S5). amPFC anterior medial prefrontal cortex, dlPFC dorsolateral PFC, PCC posterior cingulate cortex, PL parietal lobe, ROC receiver operating characteristics
Fig. 3 Diagnostic ability of imaging predictors to anticipate depression recovery: leave-one-out cross-validation (solid line, CV, n − 1 patients) vs. full sample effect size estimations (dashed line, n patients). a Explained variance remained large for all univariate models (single brain regions) prior clinical response (day 0 and especially day 1). ROC curves display the ability of the dlPFC-PL functional connectivity to differentiate also between dichotomous outcomes (remitters and non-remitters) prior a clinically observable response (day 0 and 1). Sensitivity (true positive rate) informs about correct remitter detection and specificity (1—false positive rate) about nonremitter detection. b Effect size remained similar for the multivariate model (all brain regions) after cross-validation. Overfitting, indicated by a large difference between dashed and solid lines, occurred predominantly using multivariate models at late trial stages (day 28 and day 56). This indicates shared information within this system of brain regions (for more details see Figures S4, S5 and Tables S3, S5). amPFC anterior medial prefrontal cortex, dlPFC dorsolateral PFC, PCC posterior cingulate cortex, PL parietal lobe, ROC receiver operating characteristicsCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 88 references

Research works printed but not linked: 2

  1. McGrath, C. L. et al. Toward a neuroimaging treatment selection biomarker for major depressive disorder. JAMA Psychiatry 70, 821–829 (2013). · DOI · Paper page
  2. Roiser, J. P., Elliott, R. & Sahakian, B. J. Cognitive mechanisms of treatment in depression. Neuropsychopharmacology 37, 117–136 (2012). · DOI · Paper page

Cited by

See all 53

Metadata

Authors
Meyer, B. M., Rabl, U., Huemer, J., Bartova, L., Kalcher, K., Provenzano, J., Brandner, C., Sezen, P., Kasper, S., Schatzberg, A. F., Moser, E., Chen, G., & Pezawas, L.
Affiliations
  • Medical University of Vienna (AT)
  • Stanford Medicine (US)
  • National Institute of Mental Health (US)
Corresponding author
Pezawas, Lukas
Venue
Translational Psychiatry
Published
2019-02-04
Volume
9
Issue
1
Pages
64-64
ISSN
2158-3188 (ISSN-L)
OpenAlex
W2911421502
Cited by
52
References
89
Citations by year
2026: 4 · 2025: 6 · 2024: 6 · 2023: 9 · 2022: 12 · 2021: 6 · 2020: 8 · 2019: 1
FWCI
4.18
Type
journal article
Language
en
Open access
Licence
Locations
  • Translational Psychiatry (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Lirias (KU Leuven) (submittedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Functional Brain Connectivity Studies
Keywords
major depressive disorder, recovery from depression, escitalopram, anterior medial prefrontal cortex, dorsolateral prefrontal cortex, posterior cingulate cortex, parietal lobe, working memory, Montgomery-Asberg Depression Rating Scale, treatment response prediction, fMRI biomarkers
MeSH terms
Adult, Major Depressive Disorder, Female, Gyrus Cinguli, Humans, Longitudinal Studies, Magnetic Resonance Imaging, Male, Memory, Short-Term, Nerve Net, Parietal Lobe, Prognosis, Sensitivity and Specificity, Citalopram, Outcome Assessment, Health Care, Selective Serotonin Reuptake Inhibitors, Prefrontal Cortex, Young Adult, Connectome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prefrontal networks dynamically related to recovery from major depressive disorder: a longitudinal pharmacological fMRI study. https://app.cochat.ai/papers/10.1038/s41398-019-0395-8
The paper
Meyer, B. M., Rabl, U., Huemer, J., Bartova, L., Kalcher, K., Provenzano, J., Brandner, C., Sezen, P., Kasper, S., Schatzberg, A. F., Moser, E., Chen, G., & Pezawas, L. (2019). Prefrontal networks dynamically related to recovery from major depressive disorder: a longitudinal pharmacological fMRI study. Translational Psychiatry. https://doi.org/10.1038/s41398-019-0395-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.